For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240524:nRSX7380Pa&default-theme=true
RNS Number : 7380P Cambridge Nutritional Sciences PLC 24 May 2024
Cambridge Nutritional Sciences Plc
(the "Company" or "CNSL")
Directorate Change
CNSL (AIM:CNSL), the specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and nutrition, is
pleased to announce that it has appointed James Cooper to the Board as Chief
Operating Officer ("COO") and Executive Director with immediate effect.
James graduated from the University of Cambridge in 2014 and, prior to joining
CNSL as Operations Director in January this year, has spent the previous 10
years at Chartwell Consulting Limited, a global operations consultancy firm,
working most recently on assignments in the medical and pharmaceuticals
sectors.
Carolyn Rand, Chair, said: "As a Board, we are committed to strengthening both
our operational performance and our organisation to deliver profitable growth
in an exciting market. We have created a new Board level position of COO as
part of this ongoing process and are delighted to be promoting James into the
role, who I am certain will play a key part in our future success".
Jag Grewal, Chief Executive Officer, said: "In his short time with us, James
has already made a very significant contribution to CNSL's manufacturing
operations, and I am delighted that he has agreed to step up to the role of
COO where I look forward to working closely with him to drive our business
forwards."
Contacts:
Cambridge Nutritional Sciences Plc www.cnsplc.com (http://www.cnsplc.com)
Jag Grewal, Chief Executive Officer investors@cnsplc.com
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
About Cambridge Nutritional Sciences Plc
Cambridge Nutritional Sciences Plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.
The following disclosures are made in accordance with Schedule 2(g) of the AIM
Rules for Companies:
James Samuel Cooper, aged 32, holds 265,480 ordinary shares of 4 pence each in
the capital of the Company representing 0.11 per cent. of the Company's issued
share capital. James holds no options in the Company. James has no previous
directorships or partnerships.
Save for the disclosures above, there are no further disclosures to be made in
accordance with Rule 17 and Schedule 2(g) of the AIM Rules.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAPPUWWAUPCGQW